Everolimus and Pasireotide for Advanced and Metastatic Hepatocellular Carcinoma

PURPOSE: Few treatment options are available for patients with advanced or metastatic hepatocellular carcinoma (HCC). Based on preclinical and early clinical efficacy signals and lack of overlapping toxicity, we undertook this multicenter phase II trial to estimate efficacy and safety of everolimus...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Invest New Drugs
Asıl Yazarlar: Sanoff, Hanna K., Kim, Richard, Ivanova, Anastasia, Alistar, Angela, McRee, Autumn J., O'Neil, Bert H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4487887/
https://ncbi.nlm.nih.gov/pubmed/25613083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-015-0209-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller